The global structural heart devices market, valued at approximately USD 14.89 billion in 2023, is anticipated to grow with a compound annual growth rate (CAGR) of 9.5% during the forecast period of 2024-2032. Structural heart devices are a specialized category of medical devices designed for diagnosing and treating structural abnormalities in the heart. The rising prevalence of cardiovascular diseases, congenital heart disorders, and associated comorbidities like obesity and hypertension has substantially driven the demand for these devices.
The industry is witnessing transformative growth fueled by advancements in minimally invasive technologies, innovative product designs, and improved procedural techniques. Replacement procedures, particularly transcatheter aortic valve replacement (TAVR), have gained momentum due to their high success rates and minimally invasive nature, enabling shorter recovery periods for patients.
Regional trends highlight North America as the dominant market, propelled by a strong healthcare infrastructure, robust R&D investments, and high adoption rates for advanced medical technologies. Meanwhile, the Asia-Pacific region is expected to exhibit the fastest growth, driven by an aging population, improving healthcare facilities, and increasing awareness of heart-related disorders.
Major players such as Abbott Laboratories, Edwards Lifesciences Corporation, and Boston Scientific Corporation continue to shape the competitive landscape with technological innovations, strategic partnerships, and extensive R&D investments.
Major market players included in this report are:
- 1. Abbott Laboratories
- 2. Edwards Lifesciences Corporation
- 3. Boston Scientific Corporation
- 4. Medtronic PLC
- 5. Artivion, Inc.
- 6. Biomerics
- 7. JenaValve
- 8. MicroPort Scientific Corporation
- 9. Corcym Group
- 10. Koninklijke Philips NV
- 11. Lepu Medical Technology (Beijing) Co., Ltd.
- 12. Tendyne Holdings, Inc.
- 13. Shandong JW Medical Systems
- 14. Meril Life Sciences Pvt. Ltd.
- 15. Xeltis
The detailed segments and sub-segment of the market are explained below:
By Product:
- Heart Valve Devices
- Mechanical Heart Valves
- Tissue Heart Valves
- Transcatheter Heart Valves
- Annuloplasty Rings
- Rigid Annuloplasty Rings
- Flexible Annuloplasty Rings
- Occluders & Delivery Systems
- Atrial Septal Occluders
- Ventricular Septal Occluders
- Left Atrial Appendage Occluders
- Other Products
By Procedure:
- Replacement Procedures
- Transcatheter Aortic Valve Replacement (TAVR)
- Surgical Aortic Valve Replacement (SAVR)
- Repair Procedures
- Mitral Valve Repair
- Annuloplasty
- Other Repair Procedures
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Centers
- Others
By Region:
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Years considered for the study are as follows:
- Historical year - 2022
- Base year - 2023
- Forecast period - 2024 to 2032
Key Takeaways:
- Market Estimates & Forecast for 10 years from 2022 to 2032.
- Annualized revenues and regional-level analysis for each market segment.
- Detailed analysis of geographical landscape with country-level analysis of major regions.
- Competitive landscape with information on major players in the market.
- Analysis of key business strategies and recommendations on future market approaches.